US Patent Issued to University of Massachusetts on Oct. 14 for "Hepatitis c virus NS3/4A protease inhibitors" (Massachusetts Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,441,762, issued on Oct. 14, was assigned to University of Massachusetts (Westborough, Mass.).

"Hepatitis c virus NS3/4A protease inhibitors" was invented by Celia A. Schiffer (Shrewsbury, Mass.), Akbar Ali (Westborough, Mass.), Jacqueto Zephyr (Worcester, Mass.), Ashley N. Matthew (Worcester, Mass.) and Nageswara R. Desaboini (Worcester, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides novel classes of HCV therapeutics that are orally available, safe and effective HCV NS3/4A protease inhibitors and are less susceptible to drug resistance than existing therapeutics. The invention also relates to pharmaceutical composition of th...